期刊文献+

Oct-4蛋白在直肠癌中的表达及其与患者预后的相关性

Expression of Oct-4 protein in rectal adenocarcinoma and its correlation with prognosis
下载PDF
导出
摘要 目的观察直肠腺癌组织中胚胎干细胞标志物Oct-4蛋白的表达,并对其与直肠癌患者预后的关系进行探讨。方法应用免疫组织化学ABC法检测52例直肠癌组织中Oct-4蛋白的表达,分析Oct-4蛋白表达与预后、分期、分化程度的关系。结果 Oct-4蛋白表达主要位于直肠癌细胞胞质内,其阳性细胞数为0%~18.5%,表达阴性和阳性者分别有38例(73.1%)和14例(26.9%)。Oct-4表达阳性率与性别、年龄、临床分期和病理学分级之间无相关性(P>0.05)。Oct-4表达阴性和阳性者的3年局部无复发率分别为83.5%和75.0%,两者间差异无统计学意义(P=0.583);3年无远处转移率分别为88.6%和61.9%,两者间差异有统计学意义(P=0.035);3年生存率分别为77.9%和50.0%,差异有统计学意义(P=0.037)。结论 Oct-4在直肠腺癌组织中有不同程度的表达,Oct-4阳性表达与远处转移率及总生存率相关,与3年局部无复发率无关。 Objective To investigate the expression of embryonic stem cell marker Oct-4 protein in rectal adenocarcinom and its correlation with prognosis. Methods The expression of Oct-4 protein was evaluated by immunohistochemisti7 in 52 formalin-fixed paraffin-embedded tissue samples of rectal adenocarcinoma. The correlation of Oct-4 expression with clinical outcome was analyzed by Kaplan-Meier and log-rank methods. Results The positive expression rate of Oct-4 protein in rectal adenocarcinoma was 26.9% ( 14/ 52), which was not correlated with gender, age, clinical stage, and histological grade(P 〉 0.05 ). The 3-y local recurrence-free rates in patients with negative and positive Oct-4 expression were 83.5% and 75.0% , respectively ( P = 0. 583 ) , the 3-y metastasis-free rates were 88.6% and 61.9% , respectively (P = 0. 035 ) and the 3-y overall survival rates were 77.9% and 49.0% , respectively ( P = 0. 037 ). Conclusion Embryonic stem cell marker Oct-4 expression may have prognostic significance in patients with rectal adenoearcinoma
出处 《实用肿瘤杂志》 CAS 2013年第4期381-384,共4页 Journal of Practical Oncology
关键词 直肠肿瘤 病理学 胚胎干细胞 免疫组织化学 基因表达 预后 rectal neoplasms/pathology embryonic stem ceils immunohistochemistry gene expression prognosis
  • 相关文献

参考文献2

二级参考文献143

  • 1贺荣芳,胡忠良,沈明,文继舫.胃癌组织中PTEN,VEGF,MMP-9的表达及相关性研究[J].中国普通外科杂志,2005,14(3):173-177. 被引量:39
  • 2詹友庆,孙晓卫,李威,陈映波,徐立,关远祥,李元方,徐大志.影响根治术后胃癌预后的多因素分析[J].癌症,2005,24(5):596-599. 被引量:63
  • 3严宁,张汉东,宋娟,董继华,丁玉梅.口腔鳞癌组织中转录因子Oct-4的表达及其与肿瘤干细胞相关性研究[J].临床口腔医学杂志,2006,22(11):664-667. 被引量:9
  • 4Bernards R. Cancer: cues for migration. Nature 2003; 425:247-248.
  • 5Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6:459-469.
  • 6Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308.
  • 7John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7:14-23.
  • 8Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2:826-835.
  • 9Pratap J, Javed A, Languino LR, et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol2005; 25:8581-8591.
  • 10Chinni SR, Sivalogan S, Dong Z, et al. CXCL 12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.Prostate 2006; 66:32-48.

共引文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部